Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:animal_hosts |
monkeys
prairie dogs squirrels |
gptkbp:cause |
monkeypox disease
|
gptkbp:community_health |
community education
contact tracing surveillance measures global health concern potential for outbreaks |
gptkbp:death |
1% to 10%
|
gptkbp:diagnosis |
serological testing
PCR testing similarity to chickenpox similarity to other poxviruses |
gptkbp:endemic_to |
gptkb:Nigeria
gptkb:Democratic_Republic_of_the_Congo |
gptkbp:epidemiology |
case tracking important
underreported cases possible |
gptkbp:geographic_distribution |
Central Africa
West Africa |
https://www.w3.org/2000/01/rdf-schema#label |
monkeypox virus
|
gptkbp:human_cases |
reported globally
increased incidence in 2022 |
gptkbp:incubation_period |
7 to 14 days
up to 21 days |
gptkbp:is_recognized_as |
gptkb:1970
|
gptkbp:is_similar_to |
variola virus
cowpox virus |
gptkbp:is_vulnerable_to |
smallpox vaccine
|
gptkbp:prevention |
isolation of infected individuals
avoid contact with infected animals |
gptkbp:provides_guidance_on |
CDC recommendations
WHO guidelines |
gptkbp:public_awareness |
health campaigns
increased media coverage |
gptkbp:research |
vaccine efficacy studies
ongoing studies on transmission |
gptkbp:reservoir |
rodents
|
gptkbp:risk_factor |
travel to endemic areas
contact with infected animals close contact with infected individuals |
gptkbp:scientific_classification |
notifiable disease
|
gptkbp:symptoms |
fever
rash swollen lymph nodes skin lesions 2 to 4 weeks flu-like symptoms |
gptkbp:transmission |
zoonotic transmission
|
gptkbp:treatment |
supportive care
antiviral medications investigational therapies clinical trials ongoing vaccination post-exposure |
gptkbp:variant |
Clade I
Clade II |